0.441
0.44 (0%)
As of Aug 18, 2023
Aceragen, Inc. [ACGN]
Source:
Company Overview
Aceragen, Inc is a clinical-stage biopharmaceutical company with a business strategy focused on the clinical development, and ultimately the commercialization, of drug candidates for rare disease indications characterized by small, well-defined patient populations with serious unmet medical needs.
Country | United States |
Headquarters | exton, pennsylvania |
Phone Number | 4843481600 |
Industry | manufacturing |
CEO | John Taylor |
Website | aceragen.com |